CNMD · CONMED Corp · Share Buybacks
Market Cap
$1.39B
Shares
29.95M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Utilization
24.9%
$37,400,000 used of $150,000,000
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| — | $150,000,000 | $112,600,000 | 2026-03-31 | — | 10-Q , filed 2026-04-30 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2016-12-31 | $0 | 10-K, filed 2017-02-27 |
| 2015-12-31 | $0 | 10-K, filed 2017-02-27 |
| 2014-12-31 | $16,862,000 | 10-K, filed 2017-02-27 |
| 2013-12-31 | $50,556,000 | 10-K, filed 2016-02-23 |
| 2012-12-31 | $3,923,000 | 10-K, filed 2015-02-23 |
| 2011-12-31 | $15,021,000 | 10-K, filed 2014-02-24 |
| 2010-12-31 | $22,977,000 | 10-K, filed 2013-02-25 |
| 2009-12-31 | $0 | 10-K, filed 2012-02-28 |
Key facts
CIK
816956
CUSIP
207410101
13F (30d)
66 filings
66 filers
Visit website
Investor relations